| Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848) |
|---|
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/27/2005 | WO2005007091A2 Histone deacetylase inhibitors and methods of use thereof |
| 01/27/2005 | CA2800212A1 Histone deacetylase inhibitors and methods of use thereof |
| 01/27/2005 | CA2531601A1 Polyurea polymers from secondary polyether polyamines |
| 01/26/2005 | EP1499645A1 Incorporable photoinitiator |
| 01/26/2005 | EP1499585A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 01/25/2005 | US6846939 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide |
| 01/25/2005 | US6846813 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits |
| 01/20/2005 | WO2005005396A1 Process of making di-aryl urea compounds |
| 01/20/2005 | US20050014839 Histone deacetylase inhibitors and methods of use thereof |
| 01/20/2005 | US20050014822 Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use |
| 01/20/2005 | US20050014727 Antiinflammatoy agents; antiallergens; antiproliferative agents; skin disorders; viral disorders; Alzheimer's disease; muscular disorders; antiarthritic agents |
| 01/20/2005 | CA2530776A1 Process of making di-aryl urea compounds |
| 01/19/2005 | EP1497263A1 Acyl-3-carboxyphenylurea derivatives, method for production and use thereof |
| 01/19/2005 | EP1497262A1 Acyl-4-carboxyphenylurea derivatives, method for production and use thereof |
| 01/19/2005 | EP1497261A1 Phenethanolamine derivatives |
| 01/19/2005 | EP1497260A1 Novel methoxybenzamide compounds for use in mch receptor related disorders |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1181271B1 Naphthalene ureas as glucose uptake enhancers |
| 01/19/2005 | CN1185310C Method for preparing thixotropic agent and its application |
| 01/19/2005 | CN1185219C Trans olefinic glucokinase activators |
| 01/18/2005 | US6844466 Treating or preventing emphysema, cancer and dermatological disorders |
| 01/18/2005 | US6844182 Genetically engineered microorganism which generates endotoxin; for use in biological pest control |
| 01/13/2005 | WO2003102592A3 Selective binding and analysis of macromolecules: quantitative analysis of proteins in complex mixtures |
| 01/13/2005 | WO2003084922A8 Acyl-4-carboxyphenylurea derivatives, method for production and use thereof |
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |
| 01/12/2005 | CN1184214C Alpha-acyl and alpha-heteroatom-bustituted benzene acetamide glucokinase activators |
| 01/06/2005 | WO2005000803A2 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst |
| 01/06/2005 | WO2005000794A1 Propionamide derivatives useful as androgen receptor modulators |
| 01/06/2005 | WO2004087646A3 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases |
| 01/06/2005 | US20050004183 for preventing, Syndrome X, diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis, and other disorders related to Syndrome X and cardiovascular diseases; peroxisome proliferator activated receptor (PPAR) |
| 01/05/2005 | EP1492776A2 Iodinated triglyceride analogs |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1560041A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 01/04/2005 | US6838472 Substituted urea retinoid agonists |
| 12/30/2004 | US20040266873 1-butane acid derivatives pharmaceutical compositions containing said derivatives and the use thereof |
| 12/30/2004 | US20040266767 Compounds which modulate release of one or more of the aforementioned inflammatory cytokines |
| 12/29/2004 | WO2004002940A8 Inhibitors of hcv ns5b polymerase |
| 12/29/2004 | EP1123274B1 Substituted phenyl derivatives, their preparation and use |
| 12/29/2004 | CN1181825C Use of colchinol derivatives in preparation of vascular damaging agents drug |
| 12/23/2004 | WO2004110989A1 N-hydroxy-7-(arylamino)heptanamide derivatives useful for treating hyper-proliferative disorders |
| 12/23/2004 | WO2003095438A9 Substituted phenylacetamides and their use as glucokinase activators |
| 12/23/2004 | WO2003093250A3 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 12/23/2004 | US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence |
| 12/23/2004 | US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents |
| 12/22/2004 | CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same |
| 12/16/2004 | US20040254373 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 12/16/2004 | US20040254157 ethyl 4-[(4-[[2-methyl-phenyl)amino]carbonyl]amino)phenyl]amino]-4-oxo-2-phenyl-butanoyl)amino]benzoate for treatment of inflammatory diseases and conditions mediated by integrins (atherosclerosis, asthma, obstructive pulmonary disease, allergies, diabetes, multiple sclerosis, and autoimmune disorders) |
| 12/15/2004 | EP1486484A1 Novel o-isopropylisourea salts and process for the production thereof |
| 12/15/2004 | CN1555359A Alkyl urea vitamin A protagonist i |
| 12/15/2004 | CN1555358A CCR-3 receptor antagonists v |
| 12/15/2004 | CN1555357A Substituied ureaalkyl urea vitamin A protagonist ii |
| 12/14/2004 | US6831199 Pyrimidine compounds and derivatives thereof |
| 12/09/2004 | WO2004106292A1 Haloethyl urea compounds and their use to attenuate, inhibit or prevent non-cancerous pathogenic cellular proliferation and diseases associated therewith |
| 12/09/2004 | WO2004106291A1 Haloethyl urea compounds and the use thereof to attenuate, inhibit or prevent cancer cell migration |
| 12/09/2004 | WO2004078144A3 Diphenylethylene compounds and uses thereof |
| 12/09/2004 | US20040249150 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 12/09/2004 | US20040248897 Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions |
| 12/09/2004 | US20040248815 Substituted amino acids as erythropoietin mimetics |
| 12/09/2004 | CA2568609A1 Haloethyl urea compounds and their use to attenuate, inhibit or prevent non-cancerous pathogenic cellular proliferation and diseases associated therewith |
| 12/09/2004 | CA2568607A1 Haloethyl urea compounds and the use thereof to attenuate, inhibit or prevent cancer cell migration |
| 12/09/2004 | CA2527785A1 Ionic liquid comprising uronium cations or thiouronium cations |
| 12/08/2004 | EP1484316A1 Novel propionic acid derivative |
| 12/08/2004 | EP1484313A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 12/08/2004 | EP1483241A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 12/08/2004 | EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 12/08/2004 | EP1483228A1 Nk1 antagonists |
| 12/08/2004 | EP1482926A2 Amino-methyl substituted tetracycline compounds |
| 12/08/2004 | CN1178920C Process for producing 1,3-dialkey-2-imidazolidinone |
| 12/02/2004 | WO2004103281A2 Vanilloid receptor antagonists, and methods of making and using them |
| 12/02/2004 | WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors |
| 12/02/2004 | US20040242426 For controlling weeds in agricultural crops |
| 12/02/2004 | CA2526454A1 Gel-assisted production of small particles |
| 12/01/2004 | CN1550553A Process for the preparation of (1S,4R) or (1R,4S)-1-amino-4-(methylol)-2-cyclopentene and its derivatives or its salts |
| 12/01/2004 | CN1550500A Process for the preparation of (1S,4R) or (1R,4S)-4-(2-amino-6-chloro-9-H-purine-9-group)-2-cyclopentenyl-1-methanol or its salts |
| 12/01/2004 | CN1550490A Process for the preparation of aminoalcohol and (1S,4Rú®or (1R,4S)-1-amino-4-(methylol)-2-cyclopentene or its salts |
| 11/30/2004 | US6826033 Beta 3 adrenergic receptor agonists; treatment of pollakiuria, urinary incontinence, obesity or diabetes |
| 11/25/2004 | WO2004101752A2 Compounds for treatment of inflammation, diabetes and related disorders |
| 11/25/2004 | WO2004084842A3 Inhibitors of cathepsin s |
| 11/25/2004 | WO2004007407A3 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 11/25/2004 | US20040236147 Integrin antagonist; antiinflammatory agents; antiarthritic agents; inflammatory bowel disease; lupus; multiple sclerosis; asthma; psoriasis;antidiabetic agents; cardiovascular disorders |
| 11/25/2004 | US20040235911 hydroxyamidines; antibiotic resistance |
| 11/25/2004 | US20040235835 For prophylaxis of of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis |
| 11/25/2004 | US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases |
| 11/25/2004 | CA2524780A1 Compounds for treatment of inflammation, diabetes and related disorders |
| 11/24/2004 | EP1478620A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 11/24/2004 | EP1183231B1 Cytofectin dimers and methods of use thereof |
| 11/23/2004 | US6821960 Glucagon antagonists/inverse agonists |
| 11/18/2004 | WO2004098512A2 Malonamides and malonamide derivatives as modulators of chemokine receptor activity |
| 11/18/2004 | US20040229955 Antibacterial agents |
| 11/18/2004 | US20040229949 New 3-aryl propionic acid derivatives and analogs |
| 11/18/2004 | US20040229946 Antidiabetic agents |
| 11/18/2004 | US20040229858 VLA-4 inhibitor compounds |
| 11/17/2004 | EP1117716B1 Oligomeric and high-molecular conversion products of allophanic acid esters with nucleophilic compounds , and the use thereof |
| 11/17/2004 | EP1042276B1 Thiourea compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
| 11/16/2004 | US6818635 For therapy of bacterial infections and neoplasms, |
| 11/16/2004 | US6818634 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| 11/11/2004 | WO2004096771A1 Biaryl compounds having activity at the 5ht5a receptor |
| 11/11/2004 | WO2004096758A1 Process for the preparation of a urea and formaldehyde-containting aqueous solution |
| 11/11/2004 | US20040224993 Diphenylurea compounds |